SCHEMBL6704158

SCHEMBL6704158

OCC(O)(c1ccccc1)C1CCCCC1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM2 P08172 6/20 0.60
CHRM1 P11229 5/20 0.60
CYP2D6 P10635 4/20 0.60
KCNH2 Q12809 4/20 0.60
CHRM3 P20309 3/20 0.60
CHRM4 P08173 2/20 0.60
CHRM5 P08912 2/20 0.60
TSHR P16473 2/20 0.60
GRIN2D O15399 1/20 0.60
GRIN3B O60391 1/20 0.60
HRH1 P35367 1/20 0.60
GRIN1 Q05586 1/20 0.60
GRIN2A Q12879 1/20 0.60
GRIN2B Q13224 1/20 0.60
GRIN2C Q14957 1/20 0.60
GRIN3A Q8TCU5 1/20 0.60
CYP3A4 P08684 1/20 0.60
NFKB1 P19838 1/20 0.60
TDP1 Q9NUW8 1/20 0.60
HTR1A P08908 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1847210 1.00 CHRM2 (0.60) CHRM2CHRM1CYP2D6KCNH2CHRM3
SCHEMBL6700758 1.00 CHRM2 (0.60) CHRM2CHRM1CYP2D6KCNH2CHRM3
SCHEMBL21483711 0.98 CHRM2 (0.58) CHRM2CHRM1CYP2D6KCNH2CHRM3
SCHEMBL21483712 0.98 CHRM2 (0.58) CHRM2CHRM1CYP2D6KCNH2CHRM3
SCHEMBL2933098 0.84 CHRM2 (0.66) CHRM2CHRM1CYP2D6KCNH2CHRM3
SCHEMBL12441787 0.84 CHRM2 (0.66) CHRM2CHRM1CYP2D6KCNH2CHRM3
SCHEMBL10370745 0.81 CHRM2 (0.58) CHRM2CHRM1CYP2D6KCNH2CHRM3
SCHEMBL2762931 0.81 CHRM2 (0.56) CHRM2CHRM1CYP2D6KCNH2CHRM3
SCHEMBL10516359 0.81 CHRM2 (0.64) CHRM2CHRM1CYP2D6KCNH2CHRM3
SCHEMBL10392382 0.81 CHRM2 (0.64) CHRM2CHRM1CYP2D6KCNH2CHRM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110028395-A A kind of preparation method of 4- (4- hydroxy phenyl) cyclohexanone 宁夏中星显示材料有限公司 2019-07-19 CN claimed
CN-110028395-A A kind of preparation method of 4- (4- hydroxy phenyl) cyclohexanone 宁夏中星显示材料有限公司 2019-07-19 CN disclosed
US-6825378-B2 TREATING CYCLOHEXYLPHENYL KETONE WITH YLIDE IN ANHYDROUS SOLVENT TO OBTAIN A-CYCLOHEXYLSTYRENE; DIHYDROXYLATION, OXIDATION COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2004-11-30 US disclosed
US-20040192962-A1 Process for the synthesis of enantiomerically pure cyclohexylphenyl glycolic acid COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2004-09-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040192962-A1 Process for the synthesis of enantiomerically pure cyclohexylphenyl glycolic acid GRHPR, PGD, HPD CHRM2 3010/4885CHRM1 2511/4885CYP2D6 115/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.